Drug Discovery Award

About this program

The Mark Foundation for Cancer Research’s Drug Discovery Award supports academic investigators advancing promising cancer targets toward new therapeutic agents and preclinical development. Funding covers activities from post-target validation through early lead development, complemented by guidance from experienced biopharmaceutical R&D scientists. Applicants should be academic researchers with projects focused on discovering and progressing a novel cancer therapeutic along the critical path to preclinical development.